Spots Global Cancer Trial Database for wilms tumor

Every month we try and update this database with for wilms tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors	NCT01661400	Glioma Neuroectodermal... Wilms Tumor Rhabdomyosarcom... Sarcoma, Ewing Osteosarcoma Retinoblastoma	Metronomic Cycl... Thalidomide	6 Months - 21 Years	Washington University School of Medicine
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors	NCT02867592	Adrenal Cortica... Alveolar Soft P... Central Nervous... Childhood Clear... Clear Cell Sarc... Ewing Sarcoma Hepatoblastoma Hepatocellular ... Osteosarcoma Recurrent Adren... Recurrent Alveo... Recurrent Clear... Recurrent Ewing... Recurrent Hepat... Recurrent Hepat... Recurrent Kidne... Recurrent Malig... Recurrent Osteo... Recurrent Prima... Recurrent Renal... Recurrent Rhabd... Recurrent Soft ... Recurrent Thyro... Refractory Adre... Refractory Alve... Refractory Clea... Refractory Ewin... Refractory Hepa... Refractory Hepa... Refractory Mali... Refractory Oste... Refractory Prim... Refractory Prim... Refractory Rena... Refractory Rhab... Refractory Soft... Refractory Thyr... Refractory Wilm... Renal Cell Carc... Rhabdomyosarcom... Soft Tissue Sar... Solid Neoplasm Thyroid Gland M... Wilms Tumor	Cabozantinib Cabozantinib S-... Pharmacological...	2 Years - 30 Years	National Cancer Institute (NCI)
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors	NCT02390843	Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom...	Simvastatin Cyclophosphamid... Topotecan Myeloid growth ...	1 Year - 29 Years	Emory University
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma	NCT03478462	Pediatric Solid... Pediatric Lymph... Pediatric Brain... DIPG Neuroblastoma Ewing Sarcoma Rhabdomyosarcom... Osteosarcoma	CLR 131	2 Years - 25 Years	Cellectar Biosciences, Inc.
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors	NCT02581384	Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar...	Stereotactic Bo...	- 21 Years	Dana-Farber Cancer Institute
A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor	NCT00187031	Wilms Tumor	Topotecan, Filg...	- 21 Years	St. Jude Children's Research Hospital
Impact of an Orthotic Intervention in Children With Peripheral Neuropathy	NCT03655587	Gait, Drop Foot Chemotherapy-in... Acute Lymphocyt... Rhabdomyosarcom... Wilms Tumor	Solid ankle foo... Resting night s...	5 Years - 14 Years	Children's Hospitals and Clinics of Minnesota
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors	NCT02536183	Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor...	Magnetic resona... Lyso-thermosens...	- 30 Years	Children's National Research Institute
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors	NCT02581384	Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar...	Stereotactic Bo...	- 21 Years	Dana-Farber Cancer Institute
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors	NCT05985161	Wilms Tumor Rhabdoid Tumor Malignant Perip... MPNST Nephroblastoma XPO1 Gene Mutat... Solid Tumor	Selinexor	12 Months -	Memorial Sloan Kettering Cancer Center
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)	NCT03220035	Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ependymoma Ewing Sarcoma Hepatoblastoma Langerhans Cell... Malignant Germ ... Malignant Gliom... Osteosarcoma Peripheral Prim... Recurrent Child... Recurrent Child... Recurrent Malig... Recurrent Neuro... Refractory Mali... Refractory Neur... Refractory Non-... Refractory Prim... Rhabdoid Tumor Rhabdomyosarcom... Soft Tissue Sar... Wilms Tumor	Laboratory Biom... Vemurafenib	12 Months - 21 Years	National Cancer Institute (NCI)
Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome	NCT00565903	Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor		1 Day - 95 Years	Children's National Research Institute
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)	NCT03698994	Advanced Malign... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Histi... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Rhabd... Recurrent Soft ... Refractory Epen... Refractory Ewin... Refractory Glio... Refractory Hepa... Refractory Hist... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Prim... Refractory Rhab... Refractory Rhab... Refractory Soft... Wilms Tumor	Pharmacokinetic... Ulixertinib	12 Months - 21 Years	National Cancer Institute (NCI)
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors	NCT02076906	Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor	Magnetic Resona...	- 30 Years	Children's National Research Institute
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors	NCT05985161	Wilms Tumor Rhabdoid Tumor Malignant Perip... MPNST Nephroblastoma XPO1 Gene Mutat... Solid Tumor	Selinexor	12 Months -	Memorial Sloan Kettering Cancer Center
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases	NCT01252901	Denys-Drash Syn... Frasier Syndrom... Nephrotic Syndr... Wilms Tumor		-	Universitätsklinikum Hamburg-Eppendorf
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers	NCT00141765	Wilms Tumor Fibrosarcoma Carcinoma, Roun... Nasopharyngeal ... Brain Tumor, Re...	Myeloablative C... Stem Cell Rescu...	- 21 Years	University of Michigan Rogel Cancer Center
Molecular-Guided Therapy for Childhood Cancer	NCT02162732	Neuroblastoma Medulloblastoma Glioma Ependymoma Choroid Plexus ... Craniopharyngio... Dysembryoplasti... Meningioma Primitive Neuro... Germ Cell Tumor... Rhabdomyosarcom... Non-rhabdomyosa... Ewings Sarcoma Osteosarcoma Wilms Tumor Renal Cell Carc... Malignant Rhabd... Clear Cell Sarc... Liver Tumors	Guided Therapy	13 Months - 21 Years	Milton S. Hershey Medical Center
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma	NCT02452554	Pleuropulmonary... Recurrent Malig... Recurrent Neuro... Recurrent Rhabd... Recurrent Synov... Wilms Tumor	Laboratory Biom... Lorvotuzumab Me... Pharmacological...	12 Months - 30 Years	Children's Oncology Group
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas	NCT01625351	Ewing Sarcoma Gastrointestina... Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carc... Renal Cell Carc... Melanoma Neuroblastoma Rhabdomyosarcom... Non-rhabdomyosa...	alemtuzumab fludarabine sirolimus Busulfan melphalan stem cells CliniMACS	2 Years - 21 Years	St. Jude Children's Research Hospital
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors	NCT02536183	Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor...	Magnetic resona... Lyso-thermosens...	- 30 Years	Children's National Research Institute
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation	NCT04968990	Wilms Tumor	Proton Beam Rad... DD-4A Chemother... Complete Surgic... Surgical Resect... Partial Nephrec...	-	St. Jude Children's Research Hospital
International PPB/DICER1 Registry	NCT03382158	Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd...		-	Children's Hospitals and Clinics of Minnesota
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation	NCT04968990	Wilms Tumor	Proton Beam Rad... DD-4A Chemother... Complete Surgic... Surgical Resect... Partial Nephrec...	-	St. Jude Children's Research Hospital
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation	NCT00336531	Neuroblastoma Brain Tumor Retinoblastoma Wilms Tumor Mycoses	itraconazole	- 15 Years	Samsung Medical Center
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)	NCT03213678	Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Malignant Gliom... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Soft ... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Neur... Refractory Non-... Refractory Prim... Rhabdoid Tumor Stage III Osteo... Stage III Soft ... Stage IV Osteos... Stage IV Soft T... Stage IVA Osteo... Stage IVB Osteo... Wilms Tumor	Biospecimen Col... Computed Tomogr... FDG-Positron Em... Magnetic Resona... Samotolisib X-Ray Imaging	12 Months - 21 Years	National Cancer Institute (NCI)
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)	NCT05384821	Wilms Tumor	Vincristine Irinotecan Temozolomide Etoposide Cis-Retinoic ac...	18 Months - 17 Years	Centre Oscar Lambret
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases	NCT01252901	Denys-Drash Syn... Frasier Syndrom... Nephrotic Syndr... Wilms Tumor		-	Universitätsklinikum Hamburg-Eppendorf
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial	NCT04320888	Hematopoietic a... Recurrent Epend... Recurrent Ewing... Recurrent Hepat... Recurrent Histi... Recurrent Lange... Recurrent Lymph... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Rhabd... Recurrent Rhabd... Recurrent Soft ... Recurrent WHO G... Refractory Epen... Refractory Ewin... Refractory Hepa... Refractory Hist... Refractory Lang... Refractory Lymp... Refractory Mali... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Rhab... Refractory Rhab... Refractory Soft... Refractory WHO ... Wilms Tumor	Computed Tomogr... Magnetic Resona... Positron Emissi... Radionuclide Im... Selpercatinib X-Ray Imaging	12 Months - 21 Years	National Cancer Institute (NCI)
International PPB/DICER1 Registry	NCT03382158	Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd...		-	Children's Hospitals and Clinics of Minnesota
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)	NCT02624388	Lymphoma Childhood Lymph... Solid Tumor Childhood Solid... Neuroblastoma Ewing Sarcoma Hodgkin Lymphom... Non-Hodgkin Lym... Rhabdomyosarcom... Soft Tissue Sar... Medulloblastoma Germ Cell Tumor Wilms Tumor Brain Neoplasms Medulloblastoma... Neuroectodermal...	Genistein Placebo	1 Year - 21 Years	University of Virginia
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma	NCT04040231	Mesothelioma Pleural Mesothe... Wilms Tumor	Galinpepimut-S Nivolumab Sargramostim	18 Years -	Memorial Sloan Kettering Cancer Center
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)	NCT03220035	Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ependymoma Ewing Sarcoma Hepatoblastoma Langerhans Cell... Malignant Germ ... Malignant Gliom... Osteosarcoma Peripheral Prim... Recurrent Child... Recurrent Child... Recurrent Malig... Recurrent Neuro... Refractory Mali... Refractory Neur... Refractory Non-... Refractory Prim... Rhabdoid Tumor Rhabdomyosarcom... Soft Tissue Sar... Wilms Tumor	Laboratory Biom... Vemurafenib	12 Months - 21 Years	National Cancer Institute (NCI)
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors	NCT00931931	Rhabdomyosarcom... Osteosarcoma Ewing Sarcoma Soft Tissue Sar... Neuroblastoma Wilms Tumor Malignant Perip... Clival Chordoma Non-CNS Solid T...	HSV1716	7 Years - 30 Years	Nationwide Children's Hospital
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas	NCT00152126	Neuroblastoma Central Nervous... Lymphomas Wilms Tumor	Stem Cell Trans... Busulfan, Melph...	- 25 Years	St. Jude Children's Research Hospital
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)	NCT03698994	Advanced Malign... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Histi... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Rhabd... Recurrent Soft ... Refractory Epen... Refractory Ewin... Refractory Glio... Refractory Hepa... Refractory Hist... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Prim... Refractory Rhab... Refractory Rhab... Refractory Soft... Wilms Tumor	Pharmacokinetic... Ulixertinib	12 Months - 21 Years	National Cancer Institute (NCI)
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults	NCT04483778	Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma Melanoma	second generati... second generati... Pembrolizumab	0 Years - 26 Years	Seattle Children's Hospital
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors	NCT05302921	Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Relapsed Pediat... Refractory Pedi... Melanoma Hepatoblastoma Hepatocellular ... Neuroblastoma Wilms Tumor	Cryoablation Th... Nivolumab Ipilimumab	1 Year - 39 Years	Children's National Research Institute
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors	NCT05135975	Neuroblastoma Sarcoma	Cabozantinib	18 Months - 40 Years	Nationwide Children's Hospital
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer	NCT01222780	Sarcoma Neuroblastoma Wilms Tumor Leukemia Lymphoma Brain Tumors	Marqibo	2 Years - 20 Years	Acrotech Biopharma Inc.
Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors	NCT03507491	Cancer	Gemcitabine Nab-paclitaxel	6 Months - 30 Years	Emory University
A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas	NCT01132911	Lymphoma Sarcoma WilmsTumor Neuroblastoma	Vorinostat (SAH... Velcade (PS-341...	1 Year - 21 Years	National Institutes of Health Clinical Center (CC)
Pencil Beam Scanning in Patients With Renal Tumors	NCT03810651	Renal Tumor Wilms Tumor	Proton beam rad...	0 Years - 30 Years	Children's Hospital of Philadelphia
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases	NCT01252901	Denys-Drash Syn... Frasier Syndrom... Nephrotic Syndr... Wilms Tumor		-	Universitätsklinikum Hamburg-Eppendorf
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors	NCT05135975	Neuroblastoma Sarcoma	Cabozantinib	18 Months - 40 Years	Nationwide Children's Hospital
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer	NCT01222780	Sarcoma Neuroblastoma Wilms Tumor Leukemia Lymphoma Brain Tumors	Marqibo	2 Years - 20 Years	Acrotech Biopharma Inc.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	NCT04851119	Colorectal Carc... Endometrial Car... Melanoma Neuroblastoma Ovarian Carcino... Pancreatic Duct... Recurrent Desmo... Recurrent Ewing... Recurrent Hepat... Recurrent Hepat... Recurrent Malig... Recurrent Non-H... Recurrent Osteo... Refractory Desm... Refractory Ewin... Refractory Hepa... Refractory Hepa... Refractory Mali... Refractory Non-... Refractory Oste... Solid Pseudopap... Wilms Tumor	Biospecimen Col... Dual X-ray Abso... Tegavivint X-Ray Imaging	12 Months - 30 Years	Children's Oncology Group
Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome	NCT00565903	Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor		1 Day - 95 Years	Children's National Research Institute
Pharmacokinetic Study of Doxorubicin in Children With Cancer	NCT01095926	Wilms Tumor Neuroblastoma Soft Tissue Sar... Acute Lymphobla...	doxorubicin	- 17 Years	University Hospital Muenster
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors	NCT05103631	Liver Cell Carc... Solid Tumor Wilms Tumor Malignant Rhabd... Yolk Sac Tumor Rhabdomyosarcom... Liposarcoma Embryonal Sarco...	CATCH T cells	18 Years -	Baylor College of Medicine
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors	NCT02689336	Glioma Rhabdomyosarcom... Osteosarcoma Medulloblastoma Neuroectodermal... Ependymoma Ewing's Sarcoma Wilms Tumor	Erlotinib Temozolomide	1 Year - 21 Years	Washington University School of Medicine
iCAT for Recurrent/Refractory/HR Solid Tumors	NCT01853345	Pediatric Solid... Sarcoma Neuroblastoma Wilms Tumor		- 30 Years	Dana-Farber Cancer Institute
Vascular Thrombus Involvement in Nephroblastoma	NCT05195411	Nephroblastoma ...		- 17 Years	Assistance Publique - Hôpitaux de Paris
Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital	NCT06288802	Wilms Tumor		- 18 Years	South Egypt Cancer Institute
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors	NCT02390843	Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom...	Simvastatin Cyclophosphamid... Topotecan Myeloid growth ...	1 Year - 29 Years	Emory University
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors	NCT02689336	Glioma Rhabdomyosarcom... Osteosarcoma Medulloblastoma Neuroectodermal... Ependymoma Ewing's Sarcoma Wilms Tumor	Erlotinib Temozolomide	1 Year - 21 Years	Washington University School of Medicine
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors	NCT02076906	Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor	Magnetic Resona...	- 30 Years	Children's National Research Institute
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)	NCT04897321	Pediatric Solid... Osteosarcoma Rhabdomyosarcom... Neuroblastoma Ewing Sarcoma Wilms Tumor Adrenocortical ... Desmoplastic Sm... Germ Cell Cance... Rhabdoid Tumor Clear Cell Sarc... Hepatoblastoma Melanoma Carcinoma Malignant Perip... Soft Tissue Sar...	Fludarabine Cyclophosphamid... MESNA B7-H3 CAR T cel...	- 21 Years	St. Jude Children's Research Hospital
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults	NCT03618381	Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma	second generati... second generati...	1 Year - 30 Years	Seattle Children's Hospital
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer	NCT00436657	Peritoneal Neop... Retroperitoneal... Gastrointestina... Adenocarcinoma Neuroblastoma Ovarian Neoplas... Sarcoma Adrenocortical ... Wilms Tumor Rhabdomyosarcom... Desmoplastic Sm...	CHPP of Cisplat... Abdominal Surge...	3 Years - 18 Years	M.D. Anderson Cancer Center
Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared	NCT05735977	Wilms Tumor Renal Cancer	Indocyanine Gre...	1 Day - 15 Years	Birmingham Women's and Children's NHS Foundation Trust
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)	NCT03155620	Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Histiocytic Sar... Juvenile Xantho... Langerhans Cell... Malignant Gliom... Recurrent Child... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Soft ... Refractory Ewin... Refractory Glio... Refractory Hepa... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Prim... Refractory Rhab... Refractory Rhab... Rhabdoid Tumor Stage III Osteo... Stage III Soft ... Stage IV Osteos... Stage IV Soft T... Stage IVA Osteo... Stage IVB Osteo... Wilms Tumor	Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Ensartinib Erdafitinib Laboratory Biom... Larotrectinib S... Magnetic Resona... Mutation Carrie... Olaparib Palbociclib Pharmacological... Positron Emissi... Radionuclide Im... Samotolisib Selpercatinib Selumetinib Sul... Tazemetostat Tipifarnib Ulixertinib Vemurafenib X-Ray Imaging	12 Months - 21 Years	National Cancer Institute (NCI)
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies	NCT04308330	Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Neuroblastoma Hepatoblastoma Germ Cell Tumor	Vorinostat	1 Year - 30 Years	New York Medical College
Drug Sensitivity and Mutation Profiling	NCT04956198	Ewing Sarcoma Osteosarcoma Rhabdomyosarcom... Wilms Tumor Sarcoma, Spindl... Sarcoma Rhabdoi... Childhood Sarco...		- 21 Years	Florida International University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world:

Spots Global Cancer Trial Database for wilms tumor

Every month we try and update this database with for wilms tumor cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for wilms tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.